SCHEMBL7598404

SCHEMBL7598404

O=C(Cl)Cc1ccccc1-c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.54
PTGDR2 Q9Y5Y4 1/20 0.47
FFAR4 Q5NUL3 2/20 0.47
FFAR1 O14842 1/20 0.47
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SUCNR1 Q9BXA5 3/20 0.44
KMT2A Q03164 2/20 0.43
GCG P01275 1/20 0.42
PTGS2 P35354 2/20 0.42
PTGS1 P23219 1/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FGFR1 P11362 1/20 0.41
SRC P12931 1/20 0.41
FGFR2 P21802 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6184923 0.88 CYP2C19 (0.64) CYP2C19PTGDR2FFAR4FFAR1SLC6A4
SCHEMBL3111571 0.87 KMT2A (0.56) PTGDR2FFAR4FFAR1KMT2APTGS1
SCHEMBL3540535 0.86 SUCNR1 (0.56) CYP2C19PTGDR2FFAR4FFAR1SLC6A4
SCHEMBL28888278 0.86 ABCC4 (0.44) CYP2C19FFAR4FFAR1KMT2APTGS1
SCHEMBL29636261 0.86 ABCC4 (0.44) CYP2C19FFAR4FFAR1KMT2APTGS1
SCHEMBL7600170 0.84 FFAR1 (0.46) CYP2C19PTGDR2FFAR4FFAR1SUCNR1
SCHEMBL7410920 0.84 KMT2A (0.53) PTGDR2FFAR4FFAR1KMT2APTGS1
SCHEMBL6598295 0.81 KCNA5 (0.44) CYP2C19KMT2AMAPTNPC1ALDH1A1
SCHEMBL9890714 0.80 CYP2C19 (0.49) CYP2C19PTGDR2FFAR4FFAR1SLC6A4
SCHEMBL9890715 0.80 CYP2C19 (0.49) CYP2C19PTGDR2FFAR4FFAR1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017672-B1 NEW NPY ANTAGONISTS ASTRAZENECA AB (SE) 2002-11-27 EP disclosed
US-6127414-A NPY antagonists ASTRA AKTIEBOLAG (SE) 2000-10-03 US disclosed
EP-1017672-A1 NEW NPY ANTAGONISTS AstraZeneca AB (SE) 2000-07-12 EP disclosed
WO-1999015498-A1 NEW NPY ANTAGONISTS ASTRAZENECA AB (SE) 1999-04-01 WO disclosed